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Background: Transcatheter Aortic Valve Replacement (TAVR) improves survival in inoperable patients with severe aortic stenosis (AS). Compared to 
surgical aortic valve replacement (AVR), TAVR is associated with a higher incidence of paravalvular leaks. The aortic regurgitation (AR) index has been 
shown to be associated to the severity of paravalvular leak and prognosis. Comparisons of AR indices between different transcatheter aortic valves 
are currently lacking. We present at two-center comparison of AR index between the Medtronic Core Valve and Edwards-Sapien Valve.
methods: Patients undergoing implantation with the Medtronic Core Valve were recruited in Angiografia de Occidente Cali, Colombia, from March 
24, 2008 to September 7, 2012 and patients undergoing implantation with the Edwards-Sapien valve at the University of Miami Hospital Florida, 
USA from December 1, 2011 to October 15, 2012. The AR index was calculated in all patients after deployment of the valve by subtracting the left 
ventricular end diastolic pressure from the aortic diastolic pressure and dividing by the systolic pressure.
results: A total of 64 patients underwent implantation of a Core Valve Prosthesis and 100 patients underwent implantation with an Edwards-
Sapien valve. Patients undergoing implantation of Edwards-Sapien valve were significantly older (84.5±6.7 vs. 79 ±6.1 p<0.001) and had similar 
rates of diabetes (38% vs. 31.3% p=0.38), hypertension (86% vs. 92% p=0.38), prior myocardial infarction (17% vs. 18.8% p=0.78) and COPD (36% 
vs. 45.3% p=0.24). The AR index was significantly higher for patients undergoing implantation of Core Valve vs. Edwards Sapien Valve (30.72 ± 10.4 
vs. 26.1 ± 9.3 p=0.004).
conclusions: Patients who underwent TAVR with the Medtronic Core Valve tended to have a higher AR index post-TAVR vs. those who underwent 
TAVR with the Edwards-Sapien Valve. The implications of our findings will need to be further evaluated and correlated with other clinical outcomes 
and parameters in larger randomized trials directly comparing different percutaneous valve technologies.
